AVNS as reported
Avanos Medical, Inc. reported $716M of revenue over the trailing twelve months, +3.9% on the year before. 11 reported series are charted on this page, each one as filed.
$716M
Revenue, trailing twelve months · to Q1 2026 · +3.9% against the twelve months before
- Net Income
- −$74M
Net Income · −81% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $7.5M
Free Cash Flow · −93% year on year · trailing twelve months to Q1 2026
- Op Margin
- −9.1%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $716M | +3.9% | Q1 2026 |
| Net Income | −$74M | −81% | Q1 2026 |
| EPS | −$1.60 | −81% | Q1 2026 |
| Gross Margin | 50% | n/a | Q1 2026 |
| Op Margin | −9.1% | n/a | Q1 2026 |
| Net Margin | −11% | n/a | Q1 2026 |
| ROE | −35% | n/a | Q1 2026 |
| ROA | −26% | n/a | Q1 2026 |
| ROIC | −27% | n/a | Q1 2026 |
| Free Cash Flow | $7.5M | −93% | Q1 2026 |
| P/E | 56.0 | n/a | Q1 2019 · 28 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Avanos Medical, Inc. (AVNS) - Revenue & ProfitRevenue & ProfitAvanos Medical, Inc. (AVNS)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Devices
The closest names by size in the same industry